Literature DB >> 6326847

Degradation of glomerular basement membrane by human neutrophils in vitro.

M C Vissers, C C Winterbourn, J S Hunt.   

Abstract

The glomerular basement membrane is susceptible to immunologic injury when immune complexes or anti-basement-membrane antibodies become lodged in its network. We have studied the digestion of glomerular basement membrane prepared from normal human kidney by isolated neutrophils. In the absence of immunoglobulin aggregates or immune complexes, there was little evidence of neutrophil adherence to the membrane, of release of lysosomal enzymes, or of digestion. However, when the basement membrane contained immunoglobin G (IgG) aggregates generated in situ by heating the membrane impregnated with IgG to 63 degrees C, electron micrographs showed neutrophils adherent to the basement-membrane surface and phagocytosis of smaller fragments. Lysosomal enzymes were detectable in the extracellular medium, and measurements of either total protein or hydroxyproline solubilized showed digestion of 80 micrograms basement membrane/h per 10(7) cells. Hydroxyproline solubilization was almost totally inhibited by phenylmethylsulphonyl fluoride, indicating that the neutrophil serine proteinases, elastase and cathepsin G are responsible for degradation. These findings provide direct evidence for the digestion of extracellular matrix by neutrophils stimulated in situ by deposited immune complexes as a contributor to inflammatory tissue damage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326847     DOI: 10.1016/0167-4889(84)90144-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Glomerular basement membrane-containing immune complexes stimulate tumor necrosis factor and interleukin-1 production by human monocytes.

Authors:  M C Vissers; J C Fantone; R Wiggins; S L Kunkel
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

3.  Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease.

Authors:  M Gharaee-Kermani; R Wiggins; F Wolber; M Goyal; S H Phan
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.

Authors:  R J Johnson; W G Couser; E Y Chi; S Adler; S J Klebanoff
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

5.  Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase(s) by reactive oxygen metabolites.

Authors:  S V Shah; W H Baricos; A Basci
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G.

Authors:  L W Heck; W D Blackburn; M H Irwin; D R Abrahamson
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system.

Authors:  S J Klebanoff; M G Kinsella; T N Wight
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

Review 8.  Proteinases and the glomerulus: their role in glomerular diseases.

Authors:  M Davies; G A Coles; G J Thomas; J Martin; D H Lovett
Journal:  Klin Wochenschr       Date:  1990-11-16

9.  The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo.

Authors:  R J Johnson; W G Couser; C E Alpers; M Vissers; M Schulze; S J Klebanoff
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

10.  Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase.

Authors:  G Schrijver; J Schalkwijk; J C Robben; K J Assmann; R A Koene
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.